19 June 2013
Keywords: positive, phase, ii, results, schering, ag, leukine
Article | 20 October 2003
German drugmaker Schering AG has released promising new Phase II data showing the potential utility of its Leukine (sargramostim) as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 October 2003
24 November 2003
22 September 2003
© 2013 thepharmaletter.com